Financial Ratios

HIRAN ORGOCHEM LTD.

NSE : NABSE : 506170ISIN CODE : INE546E01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.480 (0 %)
PREV CLOSE ( ) 0.48
OPEN PRICE ( ) 0.44
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.45 (417)
VOLUME 26000
TODAY'S LOW / HIGH ( )0.44 0.48
52 WK LOW / HIGH ( ) 0.440.48
NSE
This Company is not listed in NSE
Select year
ParticularsMar2015Mar2014Jun2013Jun2012Jun2011
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.81-0.73-6.08-0.92-8.45
   CEPS(Rs)-2.81-0.58-5.83-0.66-8.13
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-6.32-3.51-2.783.284.18
   Tax Rate(%)0.000.000.000.00-0.65
Margin Ratios
   Core EBITDA Margin(%)-6023.57-216.83-220.07-29.17-43.61
   EBIT Margin(%)-5848.62-236.65-223.71-16.72-43.56
   Pre Tax Margin(%)-5849.72-242.80-224.01-21.14-53.37
   PAT Margin (%)-5849.72-242.80-224.01-21.14-53.72
   Cash Profit Margin (%)-5838.68-191.99-214.73-15.11-51.65
Performance Ratios
   ROA(%)-54.90-8.88-50.13-5.26-40.15
   ROE(%)0.000.00-2423.49-24.71-139.48
   ROCE(%)-102.40-12.51-65.58-5.56-50.20
   Asset Turnover(x)0.010.040.220.250.75
   Sales/Fixed Asset(x)0.020.060.500.803.00
   Working Capital/Sales(x)-0.01-0.04-0.41-5.78-95.77
Efficiency Ratios
   Fixed Capital/Sales(x)56.4417.901.991.250.33
   Receivable days3341.48989.29188.31210.4183.67
   Inventory Days824.75131.6832.9170.7796.73
   Payable days0.003177.70378.33366.14114.94
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-0.17-0.80-0.14-2.31-0.43
   Price/Book(x)-0.08-0.13-0.280.460.84
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)165.8034.074.021.950.71
   EV/Core EBITDA(x)-2.53-16.31-1.68-16.55-1.64
   EV/EBIT(x)-2.52-12.81-1.61-10.58-1.56
   EV/CE(x)2.751.191.110.500.55
   M Cap / Sales11.221.720.330.390.23
Growth Ratio
   Net Sales Growth(%)-84.04-88.96-38.44-73.67-27.16
   Core EBITDA Growth(%)-401.5190.38-1149.4292.86-393.73
   EBIT Growth(%)-294.5888.26-733.0789.36-445.01
   PAT Growth(%)-284.6687.98-559.8289.09-1219.41
   EPS Growth(%)-284.6687.98-559.8089.09-695.74
Financial Stability Ratios
   Total Debt/Equity(x)-1.05-2.48-3.242.752.33
   Current Ratio(x)0.290.360.430.940.99
   Quick Ratio(x)0.280.350.420.910.90
   Interest Cover(x)-5278.19-38.50-735.04-3.78-4.44
   Total Debt/Mcap(x)13.8218.8911.395.942.78

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.